BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of indolyl chalcones as antitumor agents. 2010

Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Birla Institute of Technology and Science, Pilani, India. dalipk@bits-pilani.ac.in

A series of indolyl chalcones were synthesized and evaluated in vitro for their anticancer activity against three human cancer cell lines. Compounds 3b-d, 3h, 3j, 3l, 3m, 4g, and 4j showed significant cytotoxicity, particularly, indolyl chalcones 3l and 3m were identified as the most potent and selective anticancer agents with IC(50) values 0.03 and 0.09 microM, against PaCa-2 cell line, respectively.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D047188 Chalcones Derivatives of CHALCONE that are important intermediates in the formation of FLAVONOIDS with anti-fungal, anti-bacterial, anti-inflammatory, and anti-tumor properties. 1,3-Diphenyl-propanediones,1,3-Diphenyl-propenones,1,3-Diphenylpropanediones,1,3-Diphenylpropenones,Chalconoids,1,3 Diphenyl propanediones,1,3 Diphenyl propenones,1,3 Diphenylpropanediones,1,3 Diphenylpropenones
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Synthesis and biological evaluation of N-(7-indolyl)-3-pyridinesulfonamide derivatives as potent antitumor agents.
August 2002, Bioorganic & medicinal chemistry letters,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
June 2014, European journal of medicinal chemistry,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Antitumor agents. Part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation.
April 2000, Bioorganic & medicinal chemistry letters,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents.
July 2009, Archiv der Pharmazie,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation.
May 2011, Bioorganic & medicinal chemistry,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents.
January 2020, Bioorganic chemistry,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Synthesis and biological evaluation of acetylenic chalcones as novel anti-inflammatory agents.
January 2015, Medicinal chemistry (Shariqah (United Arab Emirates)),
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
5-Ethynylarylnaphthalimides as antitumor agents: Synthesis and biological evaluation.
March 2017, Bioorganic & medicinal chemistry,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Design, synthesis and biological evaluation of several aromatic substituted chalcones as antimalarial agents.
December 2020, Drug development research,
Dalip Kumar, and N Maruthi Kumar, and Kanako Akamatsu, and Eriko Kusaka, and Hiroshi Harada, and Takeo Ito
Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents.
January 1998, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!